TWiV 1321: Phage cross talk and cross reactions

Andes hantavirus transmission on a cruise ship underscores the potential for person-to-person spread and the necessity of monitoring long incubation periods. Phage therapy for cystic fibrosis patients faces significant hurdles, as demonstrated by a case where pre-existing cross-reactive antibodies and bacterial heteroresistance contributed to treatment failure. These findings highlight the importance of screening for anti-phage immunity and assessing bacterial population diversity before initiating therapy. Meanwhile, the Arbitrium system reveals a sophisticated mechanism for phage communication, where phages secrete small peptides to gauge population density and regulate the lysis-lysogeny decision. This signaling allows phages to eavesdrop on other species, creating an ecological alliance that influences host survival and microbial ecosystem dynamics. These insights into viral behavior and therapeutic limitations provide critical guidance for future clinical applications and environmental microbiology research.